[HTML][HTML] Potential biomarkers for the early detection of bone metastases

Y Hao, F Zhang, Y Ma, Y Luo, Y Zhang, N Yang…�- Frontiers in�…, 2023 - frontiersin.org
The clinical manifestations of bone metastases are diversified while many sites remain
asymptomatic at early stage. As the early diagnosis method is not perfect and the early�…

Serum CEA and CYFRA levels in ALK-rearranged NSCLC patients: Correlation with distant metastasis

T Numata, T Endo, H Yanai, K Ota, Y Yamamoto…�- in vivo, 2020 - iv.iiarjournals.org
Aim: To clarify the correlation between serum levels of carcinoembryonic antigen (CEA) and
cytokeratin 19 fragment (CYFRA) and metastasis and survival in anaplastic lymphoma�…

[HTML][HTML] Risk factor analysis of bone metastasis in patients with non-small cell lung cancer

Y Li, C Xu, Q Yu�- American Journal of Translational Research, 2022 - ncbi.nlm.nih.gov
Objective: Bone tissue is the most common metastatic location besides lung and liver. 30%~
40% of patients with non-small cell lung cancer (NSCLC) will have bone metastasis (BM) in�…

[HTML][HTML] Metabolic phenotypes, serum tumor markers, and histopathological subtypes in predicting bone metastasis: analysis of 695 patients with lung cancer in China

M Jiang, P Chen, X Zhang, X Guo, Q Gao…�- …�Imaging in Medicine�…, 2023 - ncbi.nlm.nih.gov
Background Patients with lung cancer who develop bone metastasis (BM) generally have an
adverse prognosis. Although several clinical models have been used to predict BM in�…

Development and validation of a novel nomogram for predicting tumor-distant-metastasis in patients with early T1-2 stage lung adenocarcinoma

WG Gu, MB Hu, WJ Wang, C Shi…�- Therapeutics and clinical�…, 2020 - Taylor & Francis
Background Distant metastasis in early T1-2 (diameter≤ 5 cm) stage lung adenocarcinoma
(ET-LUAD) patients largely affect treatment strategies in clinical practice. However, the�…

[HTML][HTML] Clinical risk factors of carbohydrate antigen-125, cytokeratin fragment 19, and neuron-specific enolase in liver metastases from elderly lung cancer patients

T Cheng, J Chen, P Ying, H Wei, H Shu, M Kang…�- Frontiers in�…, 2022 - frontiersin.org
Objective: Lung cancer is a common malignant tumor characterized by challenging
detection and lack of specificity in clinical manifestations. To investigate the correlation of�…

[HTML][HTML] Can Tumour Antigens Act as Biomarkers for the Early Detection of Non-Small Cell Lung Cancer?

E Mohamed, D Fletcher, S Hart, B Guinn�- Onco, 2024 - mdpi.com
Simple Summary Lung cancer (LC) is one of the most common and serious types of cancer.
Unfortunately, it is not easy to detect in the early stages of the disease due to the absence of�…

Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer

M Yu, C Yang, S Wang, Y Zeng, Z Chen, N Feng…�- Clinica Chimica�…, 2020 - Elsevier
Background The prognosis of prostate cancer (PCa) is related to tumor metastasis, among
which 80% were bone metastasis. In this study, we investigated the correlation between�…

[PDF][PDF] Aplicaciones del PET/CT en oncolog�a

JPO Gonz�lez, AM Ram�rez, RP Baum�- Nucleus, 2017 - scielo.sld.cu
PET significa Tomograf�a por Emisi�n de Positrones y es una t�cnica de medicina nuclear
en la cual se emplean radiof�rmacos marcados con emisores de positrones que permiten�…

Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy

YAO Yuanshan, Z Yinjie, Y Zhenhua…�- Zhongguo Fei Ai Za�…, 2018 - search.proquest.com
背景与目的 肺癌目前是死亡率最高的肿瘤, 非小细胞肺癌 (non-small cell lung cancer, NSCLC)
患者在手术后通常会发生远处转移, 如骨转移, 脑转移, 肺转移等. 本研究旨在探究 NSCLC�…